drugset / Trial / NCT00989521
Effect of PUR003 on Asthma
Phase 1
Completed
7 enrolled
Pulmatrix Inc.
McMaster University · collabSt. Joseph's Healthcare Hamilton / Firestone Institute for Respiratory Health · collab
RandomizedCrossoverQuadruple-blindTreatment
Summary
PUR003 is an inhaled substance that is proposed to assist in the treatment of asthma. Study objectives are to : 1. to evaluate the safety of PUR003 in subjects with asthma, and 2. to evaluate the efficacy of PUR003 in assisting the treatment of asthma.
Timeline
- Start
- 2009-12
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | PUR003 | Unknown | — | Inhaled |